Project Grant R01DA060716
Award Date
9/1/24
Completion Date
5/31/29
Dollars Obligated
$719K
Funding Federal Agency
Office of the Director
Awarding Federal Agency
National Institute on Drug Abuse
Awardee
Yale Univ (FL6GV84CKN57)
Federal Grant Program
93.310
Assistance Type
Project Grant
Place of Performance
New Haven, CT 06510, USA
Similar Awards
This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $1,589,319 to Yale University from August 2024 to June 2028. The project, "Leveraging Extensive Social Determinants Data and Spatial Data Science to Reduce HIV Incidence Across the United States Ending the HIV Epidemic Counties," aims to develop novel indicators of transportation-based PrEP accessibility, community mental health...
This $196,350 Project Grant was awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to Yale University. The grant will fund a project titled "HIV COMPLEX CAUSAL MODELING: GUT MICROBIOME, DRUG USE, AND IMMUNE RESPONSES" from August 1, 2024 to July 31, 2026. The project aims to elucidate the causal relationship between drug use disorders, HIV acquisition, gut microbiome, and immune responses using Mendelian randomization...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $820,845 to New York University School of Medicine to conduct research aimed at improving HIV outcomes across diverse settings and subgroups in the U.S. HIV epidemic. The research will use mathematical modeling to simulate alternative ways to distribute resources across interventions, settings, and target...
This $459,999 federal Project Grant award from the National Institutes of Health (NIH) Office of the Director (CFDA 93.310 - Trans-NIH Research Support) supports research by the Scripps Research Institute in La Jolla, CA to develop predictive modeling of viral RNA cellular behavior. The key objectives are to: 1) Develop high-throughput technologies that integrate 3D structural ensembles of biomolecules with quantitative measurements of in vitro and cellular functions to build predictive models...
This $191,484 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research at Beth Israel Deaconess Medical Center, Inc. (Bidmc) to use artificial intelligence (AI) to: 1) predict changes in opportunistic infection (OI) hospitalization and mortality rates for people with HIV (PWH) by simulating Medicaid expansion in the Southern U.S., 2) develop a time-series deep learning model to predict poor...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) provides $382,852 to Brown University to develop methodological innovations for improving the use of observational causal inference models to estimate the population-level impact of interventions on infectious disease outcomes. The key products and services to be delivered include: Proposing robust specifications for observational...
This Project Grant award, valued at $2,362,500 and effective from July 1, 2025 to June 30, 2029, was provided by the National Institute on Drug Abuse (NIDA) under the federal Drug Use and Addiction Research Programs (CFDA 93.279). The project aims to overcome policy and regulatory barriers that hinder access to evidence-based harm reduction and treatment services for preventing HIV transmission and overdose among people who use drugs. Key deliverables include: 1) a tool to identify policy...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $688,271 to Yale University to conduct a comprehensive research project examining the spatial and temporal variability in a state's illicit drug market. The key products and services to be delivered under this 5-year grant, which runs from June 1, 2025 to February 28, 2030, include: 1) Expanding existing street-based testing of drug samples...
The U.S. National Institute of General Medical Sciences (NIGMS) awarded a $401,248 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to the University of California, Berkeley to develop new models and methods for understanding how demographic and social processes influence infectious disease risk. The project aims to create a generalized framework for jointly modeling human behavioral changes and disease dynamics, incorporating data on human mobility, aggregation, and other...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is intended to design tailored harm reduction strategies to address the escalating drug overdose crisis in the United States. The $2,316,128 award, with a project period from September 15, 2024 to July 31, 2028, will support collaborative efforts with health departments and community partners across six jurisdictions (Rhode Island, Massachusetts, New York...